CVE-2013-5523

Description

The Sponsor Portal in Cisco Identity Services Engine (ISE) 1.2 and earlier does not properly restrict use of IFRAME elements, which makes it easier for remote attackers to conduct clickjacking attacks and unspecified other attacks via a crafted web site, related to a "cross-frame scripting (XFS)" issue, aka Bug ID CSCui82666.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.55%
Vendor Advisory cisco.com Vendor Advisory cisco.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securitytracker.com/id/1029157 vdb entry third party advisory
http://osvdb.org/98168 vdb entry
http://tools.cisco.com/security/center/content/CiscoSecurityNotice/CVE-2013-5523 vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/87724 vdb entry
http://www.securityfocus.com/bid/62869 vdb entry third party advisory
http://tools.cisco.com/security/center/viewAlert.x?alertId=31161 vendor advisory
http://secunia.com/advisories/55207 third party advisory

Frequently Asked Questions

What is the severity of CVE-2013-5523?
CVE-2013-5523 has been scored as a medium severity vulnerability.
How to fix CVE-2013-5523?
To fix CVE-2013-5523, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2013-5523 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2013-5523 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.